Esophageal Adenocarcinoma Clinical Trials in Chapel Hill, North Carolina
6 recruitingChapel Hill, North Carolina
Showing 1–6 of 6 trials
Recruiting
Phase 2
Obeticholic Acid for Prevention in Barrett's Esophagus
Esophageal AdenocarcinomaBarrett Esophagus
National Cancer Institute (NCI)30 enrolled8 locationsNCT04939051
Recruiting
Phase 2Phase 3
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Bristol-Myers Squibb690 enrolled159 locationsNCT07221149
Recruiting
Phase 3
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8+12 more
Alliance for Clinical Trials in Oncology382 enrolled786 locationsNCT05677490
Recruiting
Not Applicable
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Esophageal AdenocarcinomaBarrett EsophagusBarretts Esophagus With Dysplasia
University of Colorado, Denver680 enrolled23 locationsNCT05753748
Recruiting
Not Applicable
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
Esophageal AdenocarcinomaBarrett EsophagusGastroesophageal Reflux
Case Comprehensive Cancer Center800 enrolled5 locationsNCT06687603
Recruiting
Not Applicable
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
Esophageal AdenocarcinomaBarrett EsophagusBarretts Esophagus With Dysplasia
University of Colorado, Denver2,298 enrolled14 locationsNCT05530343